HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
1326studies shown
Showing 1,285-1,296 of 1,326
Drug study icon
Recruitment unclearEUCTR 2008-005353-38

Interventional, randomised, double-blind, placebo-controlled, active reference (fluoxetine), fixed-dose study of vortioxetine in paediatric patients aged 7 to 11 years, with Major depressive disord...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In France
DepressionHistorical research record
Countries
France, United Kingdom, Bulgaria, + 8 others
Sponsor
H. Lundbeck A/S
Drug study icon
Recruitment unclearEUCTR 2009-014056-30

Reconnaissance des expressons faciales émotionnelles chez les patients présentant un épisode dépressif magnétique transcranienne répétée du cortex préfrontal dorsolatéral droit à basse fréquence et...

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In France
DepressionHistorical research record
Countries
France
Sponsor
CHU Clermont-Ferrand
Drug study icon
Recruitment unclearEUCTR 2020-001878-29

The efficacy of traumatic memory modification using a memory reconsolidation procedure under propranolol among adolescents with post-traumatic stress disorder (PROPRADO)

Current recruitment status is unconfirmed.

This older record does not confirm current recruitment. No matching public CTIS record was confirmed using this identifier. Ask the research team for an up-to-date source.

In France
PTSDHistorical research record
Countries
France
Sponsor
Rennes University Hospital
Drug study icon
Not recruitingEUCTR 2008-002676-10

A 38-week, Multicenter, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Mai...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
SchizophreniaHistorical research record
Countries
France, Belgium, Austria, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
Not recruitingEUCTR 2008-002699-83

A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of Aripiprazole Intramuscular Depot as Maintenance Treatment in Patients with Schizophrenia "ASPIRE OPEN-LABEL" (Aripiprazole...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
SchizophreniaHistorical research record
Countries
France, United Kingdom, Belgium, + 7 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
Not recruitingEUCTR 2009-016648-38

A 6-Month, Open-Label, Flexible-Dosage (150 to 200 mg/day) Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With ...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
Depression, BipolarityHistorical research record
Countries
France, Bulgaria, Finland, + 5 others
Sponsor
Cephalon, Inc.
Drug study icon
Not recruitingEUCTR 2017-001459-30

A Long-term, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Flexible-Dose Brexpiprazole as Maintenance Treatment in Adolescents (13-17 Years Old) With Schizophrenia

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
SchizophreniaHistorical research record
Countries
France, Bulgaria, Hungary, + 4 others
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc
Drug study icon
Not recruitingEUCTR 2008-001581-91

A Long-Term, Open-Label, Flexible-Dose, Extension Study Evaluating the Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
DepressionHistorical research record
Countries
France, United Kingdom, Germany, + 3 others
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd.
Drug study icon
Not recruitingEUCTR 2006-003080-31

A multi-center, double-blind, flexible-dose efficacy trial with Org 25935 versus placebo as add-on therapy in subjects with predominant, persistent negative symptoms of schizophrenia treated with a...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
SchizophreniaHistorical research record
Countries
France, Austria, Czechia, + 1 other
Sponsor
NV Organon
Drug study icon
Not recruitingEUCTR 2005-004391-21

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP STUDY, COMPARING THE EFFICACY AND TOLERABILITY OF ZIPRASIDONE (ZELDOX®, GEODON®) VS OLANZAPINE (ZYPREXA®) IN THE TREATMENT AND MAINTENANCE OF...

This study isn't currently recruiting.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In France
BipolarityHistorical research record
Countries
France, Germany, Greece, + 2 others
Sponsor
Pfizer S.A.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.